Generic Drugs

Sep 09, 2015
By Pharmaceutical Technology Editors
Lannett Company agreed to purchase Kremers Urban Pharmaceuticals, the US specialty generic-pharmaceuticals subsidiary of global biopharmaceuticals company UCB S.A., for $1.23 billion.
Sep 01, 2015
Pharmaceutical Technology
An analysis of controlled correspondence between generic-drug manufacturers and FDA reveals patterns in questions about specific drug chemistry topics and the response to information provided in FDA guidance documents.
Aug 28, 2015
By Pharmaceutical Technology Editors
Growth is said to be driven by the deeper penetration of biosimilars in developed and emerging markets as a result of clearer regulatory pathways.
Aug 27, 2015
In a new draft guidance, FDA proposes the use of a nonproprietary name plus a four-letter suffix to identify all biologic products, both new and old.
Aug 05, 2015
By Pharmaceutical Technology Editors
US generics manufacturer Amneal acquires a former J&J plant in Ireland.
Jul 09, 2015
By Pharmaceutical Technology Editors
Teva has launched the generic version of almotriptan malate (Axert), 6.25 mg and 12.5 mg, in the United States.
Jun 19, 2015
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
The agency takes action against websites that illegally sell unapproved medications.
Jun 15, 2015
By Pharmaceutical Technology Editors
BPTF seeks changes in performance goals and fee payment schedule in GDUFA renegotiations.
Jun 09, 2015
By Pharmaceutical Technology Editors
The product, marketed as Sirdupla in the United Kingdom, is the generic version of GSK’s beta agonist and corticosteroid combination treatment for asthma.
Jun 08, 2015
In a Citizen Petition to FDA, AbbVie calls the current biosimilar labeling practices “legally unsound.”
native1_300x100
lorem ipsum